AzTrials
AzTrials

Pelvic Gynecological CancerHYPPOGYNNCT03281018

Preoperative Hypnosis in Gynecology

A study testing Caregiver Accompaniment Time (CAT) + preoperative hypnosis session in people with Pelvic Gynecological Cancer, run by University Hospital, Bordeaux at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The research hypotheses that preoperative formal hypnosis session reduces perioperative anxiety among women undergoing a hysterectomy for pelvic gynecological cancer. The key objective is to estimate the effect of preoperative hypnosis on preoperative anxiety among this population Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Pelvic Gynecological Cancer
What is being tested?
Caregiver Accompaniment Time (CAT) + preoperative hypnosis session
Could I receive a placebo?
No, everyone receives an active treatment
How many people
29 participants
Where
1 siteFrance
Study dates
10 Nov 2017to 26 Jun 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • ≥ 18yrs with pelvic gynecological cancer (endometrium, cervix, ovary),
  • at any stage of the disease;
  • patient coming for anesthesia consultation before hysterectomy,
  • informed signed consent,
  • patient affiliated to or beneficiary of social security.

Who cannot join

  • patient <18yrs,
  • patient with a pelvic gynecological cancer that does not require hysterectomy;
  • patient with psychiatric history or a depressive syndrome;
  • deaf patient (deafness makes the hypnosis session impossible),
  • patient under legal protection.

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHU Bordeaux

    Bordeau, 33000

Other trials in France

About this study

Official title: Exploratory Study of the Impact of a Preoperative Formal Hypnosis Session on Perioperative Anxiety Among Female Patients Hospitalised for Hysterectomy Due to Pelvic Gynecological Cancer

The research hypotheses that preoperative formal hypnosis session reduces perioperative anxiety among women undergoing a hysterectomy for pelvic gynecological cancer. The key objective is to estimate the effect of preoperative hypnosis on preoperative anxiety among this population

Read the detailed description

Anxiety is present preoperatively in 40% of patients. The operated subjects are on average 20% more anxious than the general population, according to a study of 2013. Cancer as well as surgery modifying the body pattern and impairing femininity are risk factors for preoperative anxiety. Recent work in both children and adults has shown that significant levels of preoperative anxiety increase the risk of postoperative complications and the occurrence of postoperative emotional and behavioral disorders. The consequences of hysterectomy increase patients' anxiety, for fear of affecting femininity, and the modification of the body regimen. The prevention of preoperative anxiety in such population is therefore a major issue.

Being tested
Caregiver Accompaniment Time (CAT) + preoperative hypnosis session
Keywords
hypnosis, preoperative anxiety, hysterectomy, hospitalisation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Caregiver Accompaniment Time (CAT) + preoperative hypnosis sessionBehavioural

    The hypnosis session is performed by a nurse trained in medical hypnosis; this interview lasts approximately one hour and is carried out 5 to 15 days before the hospitalisation. During the hypnosis session, the patient is free to choose what issues she wants to address. The patient will then go from a state of ordinary consciousness to a modified state of consciousness. This state will allow her to activate her own resources to handle difficulties, especially anxiety. Using a post-hypnotic suggestion, the patient will be able to revisit her work at any time she needs

Study groups in NCT03281018
Study groupRoleWhat they receive
Interventional armExperimentalCaregiver Accompaniment Time (CAT) + preoperative hypnosis session (experimental arm): The hypnosis session is performed by a nurse trained in medical hypnosis; this interview lasts approximately one hour and is carried out 5 to 15 days before the hospitalisation. During the hypnosis session, the patient is free to choose what issues she wants to address. The patient will then go from a state of ordinary consciousness to a modified state of consciousness. This state will allow her to activate her own resources to handle difficulties, especially anxiety. Using a post-hypnotic suggestion, the patient will be able to revisit her work at any time she needs
Receives: Behavioral: Caregiver Accompaniment Time (CAT) + preoperative hypnosis session
Control (CAT)No interventionCAT is performed in routine care for all patients after the announcement of the illness by a trained nurse, if possible on the same day as the consultation or before the consultation of anesthesia. This is an interview of approximately 45 minutes to listen to the patient, to answer her questions and to re-explain the information delivered to her. The patient will tackle the history of the disease and then the treatment, this time dedicated evolves according to the desire of the patient and her ability to accept the disease. The patient can express her feelings, then the family circle is evoked talking about the resource persons and the future. The purpose of this interview is to obtain the autonomy of the patient by the setting up of supportive care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. evolution of anxiety

    visual analog scale (from 0, no anxiety to 10, extreme anxiety)

    Measured: 1 month after the surgery

Secondary outcomes (6)
  1. pain

    numerical scale of pain (from 0, no pain, to 10, extreme pain)

    Measured: The day of the consultation with anesthesist, the day before the surgery, 2 days, an average of 12 days, and 1 month after the surgery

  2. nausea and vomiting

    frequency and intensity through an interview with a nurse

    Measured: 2 days, an average of 12 days, and 1 month after the surgery

  3. concomitant medication

    concomitant medication within anxiolytic, antalgic, and/or antiemetic pharmaceutical classes (yes/no)

    Measured: The day of the consultation with anesthesist, the day before the surgery, 2 days, an average of 12 days, and 1 month after the surgery

  4. medical history

    chronic pathologies (e.g. arterial hypertension, type 2 diabetes) (yes/no)

    Measured: The day of the consultation with anesthesist

  5. length of hospital stay

    Measured: an average of 12 days after the surgery

  6. hypnosis intervention feasibility (composite outcome)

    Compliance with the formal Hypnosis session checklist (Installation, pre-session interview, kinesthetic induction, dissociation, deepening, post-hypnotic suggestions and anchoring, return to normal wakefulness)

    Other factors: proportion of refusals, proportion of abandoned, proportion of lost sight

    Measured: after the hypnosis session (average of 1 week before the surgery)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Sep 2017
  2. Study start10 Nov 2017
  3. Primary completion26 Jun 2019
  4. Study completion26 Jun 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
29 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03281018
Sponsor's protocol ID
CHUBX 2016/18
Other IDs
2017-A00084-49
Acronym
HYPPOGYN
Status last verified
Jul 2019
First submitted
1 Sep 2017
Last updated
14 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Sourzac J, Berger V, Conri V. [The impact of conversational hypnosis on the pre- and postoperative anxiety of patients in gynecological surgery versus ordinary practice: A comparative study]. Rech Soins Infirm. 2018 Dec;(135):83-90. doi: 10.3917/rsi.135.0083. French.

    PubMed 30767472

Questions about this trial

What is this clinical trial studying?

A study testing Caregiver Accompaniment Time (CAT) + preoperative hypnosis session in people with Pelvic Gynecological Cancer, run by University Hospital, Bordeaux at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

evolution of anxiety (time frame: 1 month after the surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03281018, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 May 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in